Document is current
Any future updates will be listed below
-
Authors
Al-Ozairi, Ebaa
Ridge, Katie
Taghadom, Etab
de Zoysa, Nicole
Tucker, Clare
Stewart, Kurtis
Stahl, Daniel
Ismail, Khalida
-
Funding
Funding for this research was provided by:
Kuwait Foundation for the Advancement of Sciences
- License Information
-
More Information
Article History
Received: 17 July 2018
Accepted: 19 October 2018
First Online: 12 November 2018
Ethics approval and consent to participate
: Ethics approval given by the Ethics Committee at the Dasman Diabetes Institute, Kuwait RA/049/2012, 10/06/2012. All participants gave written informed consent before enrolling in the study.
: Not applicable.
: KI has received speaking fees for Janssen, Eli-Lilly, Novo Nordisk and Sanofi. Otherwise the study team has no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
